Scientists develop new MRI contrast agent to detect breast cancer tumour and micrometastases

A new magnetic resonance imaging (MRI) contrast agent has been developed by Case Western Reserve University (CWRU) scientists that can detect smaller aggressive breast cancer tumours and micrometastases.

Publisher Name
Medical Device Network